Mastodon

Ostrota Chuvsts (Drops) Instructions for Use

Marketing Authorization Holder

Mercana Service, LLC (Russia)

Manufactured By

Kurortmedservis, LLC (Russia)

Or Manufactured By

PLUTON-PHARM, CJSC (Russia)

Dosage Form

Bottle OTC Icon Ostrota Chuvsts Oral drops: bottle 25 ml, 50 ml, or 100 ml

Dosage Form, Packaging, and Product Composition

Oral drops 100 ml
Biologically active components, not less than
Content of the sum of flavonol glycosides in terms of rutin 2 %

Composition condensed extract of a herbal complex (leaves of common cowberry, buds of silver birch, rhizomes and roots of elecampane, rhizomes of sweet flag, herb of St. John’s wort, linden flowers), citric acid, ascorbic acid, sodium benzoate, sweetener, water.

25 ml – bottles with a dropper or mechanical dispenser.
50 ml – bottles with a dropper or mechanical dispenser.
100 ml – bottles with a dropper or mechanical dispenser.

Properties

Dietary supplement.

It helps to reduce the risk of atherosclerosis development, improves memory, and improves visual and hearing acuity.

It has a moderate tonic, hypoglycemic, and anti-edema effect.

The rhizomes of elecampane and sweet flag help improve cerebral circulation, strengthen the vascular wall, and have neurotrophic and nootropic effects.

Scope of Application

As an additional source of vitamins A, B, C, which helps improve memory, vision, and prevent atherosclerosis; as a moderate tonic and hypoglycemic agent, for strengthening vascular walls and improving cerebral circulation; for specialists whose work is associated with the analysis and processing of a large volume of information.

It is most suitable for middle-aged and elderly persons.

ICD codes

ICD-10 code Indication
E50 Vitamin A deficiency
E53.9 Vitamin B deficiency, unspecified
E54 Deficiency of ascorbic acid
H53.1 Subjective visual disturbances
Z73.3 Stress, not elsewhere classified (physical and mental strain)
ICD-11 code Indication
5B55.Z Vitamin A deficiency, unspecified
5B56.Z Vitamin C deficiency, unspecified
5B7Z Malnutrition, unspecified
9D51 Transient vision loss
9D5Z Subjective visual disturbances, unspecified
ED31 Burning feet syndrome
QE01 Stress, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Orally, 2 times/day. The course of application is 4-6 weeks.

Side effects

Increased heartburn, epigastric pain; rarely — skin itching.

Contraindications

Hypersensitivity to the product components, hay fever, gastric and duodenal ulcer.

Special instructions

It is not a medicinal product.

Before using the product, consult a doctor.

Do not exceed the recommended dose of the product used.

In children, use only dietary supplements intended for the corresponding age group.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS